# Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression

> **NCT00179244** · PHASE3 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 30 (—)

## Conditions studied

- Unipolar Depression

## Interventions

- **DRUG:** Rispridone (drug) and Bupropion ER (drug)

## Key facts

- **NCT ID:** NCT00179244
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 30 (—)
- **Last updated:** 2015-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00179244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00179244, "Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00179244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*